loadpatents
Patent applications and USPTO patent grants for Kindon; Nicholas.The latest application filed is for "compounds - 801".
Patent | Date |
---|---|
Compounds-801 Grant 8,476,265 - Alcaraz , et al. July 2, 2 | 2013-07-02 |
Compounds--801 Grant 8,455,483 - Alcaraz , et al. June 4, 2 | 2013-06-04 |
Compounds - 801 App 20130018037 - Alcaraz; Lilian ;   et al. | 2013-01-17 |
Compounds - 801 App 20110053909 - Alcaraz; Lilian ;   et al. | 2011-03-03 |
Novel N-(fluoro-pyrazinyl)-phenylsulfonamides As Modulators Of Chemokine Receptor Ccr4 App 20100144759 - CHESHIRE; David ;   et al. | 2010-06-10 |
N-pyrazinyl-phenylsulphonamides And Their Use In The Treatment Of Chemokine Mediated Diseases App 20100081670 - Baxter; Andrew ;   et al. | 2010-04-01 |
N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases Grant 7,662,825 - Baxter , et al. February 16, 2 | 2010-02-16 |
Novel N-(Fluoro-Pyrazinyl)-Phenylsulfonamides as Modulators of Chemokine Receptor Ccr4 App 20080293742 - Cheshire; David ;   et al. | 2008-11-27 |
Compounds Grant 7,410,972 - Baxter , et al. August 12, 2 | 2008-08-12 |
Novel condensed n-pyrazinyl-sulphonamides and their use in the treament of chemokine mediated diseases App 20070093491 - Baxter; Andrew ;   et al. | 2007-04-26 |
N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases App 20060025423 - Baxter; Andrew ;   et al. | 2006-02-02 |
Compounds Grant 6,946,478 - Baxter , et al. September 20, 2 | 2005-09-20 |
Novel compounds App 20050075346 - Baxter, Andrew ;   et al. | 2005-04-07 |
P2X7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular disease Grant 6,812,226 - Baxter , et al. November 2, 2 | 2004-11-02 |
Novel compounds App 20030134840 - Baxter, Andrew ;   et al. | 2003-07-17 |
P2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases App 20030040513 - Baxter, Andrew ;   et al. | 2003-02-27 |
Compounds Grant 6,518,286 - Baxter , et al. February 11, 2 | 2003-02-11 |
Novel compounds App 20020086862 - Baxter, Andrew ;   et al. | 2002-07-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.